
Theravance Biopharma (TBPH) Market Capitalization Overview
Market Cap: $534.52M as of Jun 13, 2025
$534.52M
Past Month+$77.51M (16.96%)
As of Jun 13, 2025, Theravance Biopharma (TBPH) has a market capitalization of $534.52M. Over the past 30 days, its market cap has increased by 7.31%, while in the last 12 months, it has increased by 15.51%.
Market capitalization represents the total value of Theravance Biopharma as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.
Theravance Biopharma (TBPH) Market Cap Formula = Stock Price * Shares Outstanding
The market cap of Theravance Biopharma (TBPH) helps investors assess the company's size and compare it with competitors for better investment decisions.
Market capitalization represents the total value of Theravance Biopharma as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.
Theravance Biopharma (TBPH) Market Cap Formula = Stock Price * Shares Outstanding
The market cap of Theravance Biopharma (TBPH) helps investors assess the company's size and compare it with competitors for better investment decisions.
Theravance Biopharma (TBPH) Market Cap & Key Trends
See Theravance Biopharma’s latest market capitalization, historical trends, and financial insights with AI-powered fundamental data and custom analysis.
Start investing in Theravance Biopharma (TBPH)
Order type
Buy in
Order amount
Est. shares
0 shares
Theravance Biopharma (TBPH) Market Cap History
Date | Market Cap | Change |
---|---|---|
Jun 2, 2025 | $557.52M | +7.31% |
May 1, 2025 | $519.52M | +16.42% |
Apr 1, 2025 | $446.23M | -0.83% |
Mar 3, 2025 | $449.95M | -3.38% |
Feb 3, 2025 | $465.69M | +2.05% |
Jan 2, 2025 | $456.34M | -1.69% |
Theravance Biopharma (TBPH) End of Year Market Cap History
Date | Market Cap | Change |
---|---|---|
2025 | $534.52M | +15.51% |
2024 | $462.74M | -17.33% |
2023 | $559.73M | -25.95% |
2022 | $755.85M | -7.19% |
2021 | $814.37M | -28.37% |
2020 | $1.14B | — |
FAQs About Theravance Biopharma (TBPH) Market Cap
As of Jun 13, 2025, the market capitalization of Theravance Biopharma (TBPH) is $534.52M. Market cap represents the total value of a company’s outstanding shares and is a key indicator of its size in the stock market.
In the last 30 days, Theravance Biopharma’s market capitalization has increased by 16.96%, changing from $457.02M to $534.52M as of Jun 13, 2025.
In the last 3 months, Theravance Biopharma’s market capitalization has increased by —, changing from – to – as of –.
In the year 2024, Theravance Biopharma’s market capitalization decreased from $559.73M in January to $462.74M in December, reflecting a -17.33% change.
In the past five years, Theravance Biopharma (TBPH) has had a compound annual growth rate (CAGR) of -16.46% in market capitalization. This means its market cap has shrunk at an average rate of -16.46% per year.